ArticleESMO real world data and digital oncology2026
Opportunities and challenges in implementing digital patient-centred cancer care in Europe-a qualitative study of several ESMO Designated Centres.
Article in ESMO real world data and digital oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Patient-centred care (PCC) improves patient outcomes in cancer care, such as survival and quality of life, yet it remains inconsistently implemented across Europe due to system- and provider-level barriers that favour disease-centred models. Guided by expert perspectives from the ESMO Designated Centres (DCs), the European Union-funded MyPath project is developing a digital solution incorporating patient-reported outcome measures to operationalise PCC across diverse European contexts. This study aims to explore challenges and opportunities for implementing digital solutions to enhance PCC in oncology, ensuring relevance and scalability across Europe using insights from ESMO DCs. Materials and Methods: A qualitative study was conducted through three semistructured focus groups with 21 clinicians and leaders from 14 ESMO DCs across 14 European countries. Qualitative analysis, guided by the Technology, People, Organisations, and Macroenvironment (TPOM) framework, identified multilevel implementation factors. Results: The analysis identified three main themes: (i) Challenges in adapting a digital PCC solution across diverse health care settings, where heterogeneity in health care organisation, resources, and political systems challenges universal implementation; (ii) The complexity of providing PCC in digital formats, highlighting the tension between standardised and flexible care; and (iii) The need for training and cultural shifts to support successful implementation, describing the need to adjust clinical behaviours and workflows to foster PCC. Conclusions: Effective digital PCC depends not only on technical integration and clinical training but also on adaptability to different care settings, infrastructures, and professional cultures. This study highlights the conditions for scalable implementation of digital PCC across Europe, offering practical implications for health system leaders and policymakers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.